First reported at 510 shares this quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-12-31 | 41000 |
| 2022-03-31 | 33000 |
| 2022-06-30 | 0 |
| 2022-12-31 | 3 |
| 2023-03-31 | 0 |
| 2023-06-30 | 2096 |
| 2023-09-30 | 0 |
| 2024-03-31 | 400519 |
| 2024-06-30 | 224610 |
| 2024-09-30 | 167663 |
| 2024-12-31 | 44682 |
| 2025-03-31 | 8287 |
| 2025-06-30 | 0 |
| 2025-06-30 | 19389 |
| 2025-09-30 | 8335 |
| 2025-12-31 | 1029 |
| 2026-03-31 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q1 2026 | Reduced | 0 | -334 (-100.0%) | 0 | $0 | 2026-05-15 | |
| Q4 2025 | Reduced | 334 | -943 (-73.8%) | < 0.01% | $1,029 | 2026-02-13 | |
| Q3 2025 | Reduced | 1,277 | -887 (-41.0%) | < 0.01% | $8,335 | 2025-11-14 | |
| Q2 2025 | New | 2,164 | +2,164 (0.0%) | < 0.01% | $19,389 | 2025-08-15 | |
| Q2 2025 | Reduced | 0 | -65,619 (-100.0%) | 0 | $0 | 2025-08-15 | |
| Q1 2025 | Reduced | 65,619 | -150,866 (-69.7%) | < 0.01% | $8,287 | 2025-05-15 | |
| Q4 2024 | Reduced | 216,485 | -435,896 (-66.8%) | < 0.01% | $44,682 | 2025-02-14 | |
| Q3 2024 | Reduced | 652,381 | -159,364 (-19.6%) | < 0.01% | $167,663 | 2024-11-14 | |
| Q2 2024 | Added | 811,745 | +747,353 (1160.6%) | < 0.01% | $224,610 | 2024-08-14 | |
| Q1 2024 | New | 64,392 | +64,392 (0.0%) | < 0.01% | $400,519 | 2024-05-15 | |
| Q3 2023 | Reduced | 0 | -510 (-100.0%) | 0 | $0 | 2023-11-15 | |
| Q2 2023 | New | 510 | +510 (0.0%) | < 0.01% | $2,096 | 2023-08-14 | |
| Q1 2023 | Reduced | 0 | -1 (-100.0%) | 0 | $0 | 2023-05-15 | |
| Q4 2022 | New | 1 | +1 (0.0%) | < 0.01% | $3 | 2023-02-14 | |
| Q2 2022 | Reduced | 0 | -8,085 (-100.0%) | 0 | $0 | 2022-08-15 | |
| Q1 2022 | Reduced | 8,085 | -1,346 (-14.3%) | < 0.01% | $33,000 | 2022-05-13 | |
| Q4 2021 | Reduced | 9,431 | -20,732 (-68.7%) | < 0.01% | $41,000 | 2022-02-14 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
44 managers reported LYRA THERAPEUTICS INC for Q2 2023.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | Added | 12,757,562 | +3,610,832 | 1.52% | $52,433,579 | 13 qtrs |
| ARMISTICE CAPITAL LLC | New | 4,012,036 | +4,012,036 | 0.24% | $16,489,468 | 1 qtr |
| Nantahala Capital Management LLC | Added | 3,957,542 | +1,736,712 | 1.57% | $16,265,497 | 5 qtrs |
| CITADEL ADVISORS LLC | Added | 2,849,178 | +2,841,244 | < 0.01% | $11,710,122 | 4 qtrs |
| Samsara BioCapital LLC | Added | 2,780,261 | +1,003,010 | 2.01% | $11,426,873 | 5 qtrs |
| PURA VIDA INVESTMENTS LLC | Reduced | 1,413,242 | -583,730 | 0.76% | $5,717,732 | 9 qtrs |
| Ikarian Capital LLC | Added | 978,626 | +634,941 | 0.64% | $4,022,153 | 12 qtrs |
| VR Adviser LLC | Unchanged | 924,170 | 0 | 0.61% | $3,798,339 | 5 qtrs |
| VANGUARD GROUP INC | Unchanged | 790,936 | 0 | < 0.01% | $3,250,747 | 13 qtrs |
| Parkman Healthcare Partners LLC | New | 600,000 | +600,000 | 0.43% | $2,466,000 | 1 qtr |
Filing details and methodology As reported
- Report period
- June 30, 2023
- Filed
- August 14, 2023
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
- Sole
- 510
- Shared
- 0
- None
- 0
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.